Europe - Frankfurt Stock Exchange - FRA:RHK - DE0007042301 - Common Stock
Taking everything into account, RHK scores 5 out of 10 in our fundamental rating. RHK was compared to 26 industry peers in the Health Care Providers & Services industry. While RHK has a great health rating, its profitability is only average at the moment. RHK is quite expensive at the moment. It does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| ROIC | 2.67% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.86% | ||
| PM (TTM) | 2.28% | ||
| GM | 66.81% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.09 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.16 | ||
| Fwd PE | 17.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.57 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE.
ChartMill assigns a valuation rating of 2 / 10 to RHOEN-KLINIKUM AG (RHK.DE). This can be considered as Overvalued.
RHOEN-KLINIKUM AG (RHK.DE) has a profitability rating of 4 / 10.
The financial health rating of RHOEN-KLINIKUM AG (RHK.DE) is 7 / 10.
The dividend rating of RHOEN-KLINIKUM AG (RHK.DE) is 2 / 10 and the dividend payout ratio is 17.78%.